GLASGOW, Scotland--(BUSINESS WIRE)--Dxcover Limited, a clinical-stage liquid biopsy company pioneering Multi-Omic Spectral Analysis for early detection of cancer, today announced that findings from a ...

CIC bioGUNE leads a study showing that multi-omic data can identify silent and stable risk profiles in healthy individuals The study, conducted using local cohorts from the Basque Country, ...

Multiple myeloma (MM) is a genetically heterogeneous malignancy characterized by variable treatment responses. Although numerous drugs have been approved in recent years, the ability to predict ...

An analysis of more than 100,000 colorectal cancer cases and 154,000 healthy controls published in Nature Genetics uncovered hundreds of signals that may serve as new treatment and prevention targets.

GLASGOW, Scotland--(BUSINESS WIRE)--Dxcover Limited, a clinical-stage liquid biopsy company pioneering Multi-Omic Spectral Analysis for early detection of cancer, today announced that it has been ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

The Analytics group provides biostatistical and bioinformatic assistance to the Duncan Cancer Center investigators and can also collaborate with Baylor College of Medicine investigators. Services span ...

Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights. By adopting best ...

Cambridge-based CardiaTec has raised $6.5mn to accelerate drug discovery for cardiovascular diseases, such as heart attacks and strokes. Cardiovascular diseases are the leading cause of death globally ...

Uptake of KRAS Testing and Anti-EGFR Antibody Use for Colorectal Cancer in the VA Multiple myeloma (MM) is a genetically heterogeneous malignancy characterized by variable treatment responses.